GAVILYTE-N (polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate)
**Product type:** Human Prescription Drug
**Active ingredient:** POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
**Strength:** 420; 1.48; 5.72; 11.2 g/438.4g; g/438.4g; g/438.4g; g/438.4g
**Dosage form:** Powder, For Solution
**Route:** Oral
**Labeler:** Lupin Pharmaceuticals,Inc.
**Marketing category:** ANDA (ANDA090019)
**Pharmacologic class:** Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
/api/v1/systems/ndc_fda/nodes/43386-050Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.